Drug, Biologic Policy Staff Return To US FDA, As RIF Process Hangs In Legal Limbo
The FDA employees with reduction-in-force notice rescissions include some who work on user fee negotiations, but staff still subject to RIFs will not officially separate from the agency this week due to ongoing legal challenges.
